Your browser doesn't support javascript.
loading
Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants.
Wang, Fengze; Li, Li; Dou, Yang; Shi, Rui; Duan, Xiaomin; Liu, Hongchuan; Zhang, Jing; Liu, DanDan; Wu, Jing; He, Yang; Lan, Jun; Lu, Bai; Feng, Hui; Yan, Jinghua.
Afiliação
  • Wang F; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Li L; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Dou Y; Shanghai Junshi Biosciences Co. Ltd, Shanghai, People's Republic of China.
  • Shi R; School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing, People's Republic of China.
  • Duan X; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Liu H; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Zhang J; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Liu D; Shanghai Junshi Biosciences Co. Ltd, Shanghai, People's Republic of China.
  • Wu J; Shanghai Junshi Biosciences Co. Ltd, Shanghai, People's Republic of China.
  • He Y; Shanghai Junshi Biosciences Co. Ltd, Shanghai, People's Republic of China.
  • Lan J; Shanghai Junshi Biosciences Co. Ltd, Shanghai, People's Republic of China.
  • Lu B; Shanghai Junshi Biosciences Co. Ltd, Shanghai, People's Republic of China.
  • Feng H; Beijing Advanced Innovation Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing, People's Republic of China.
  • Yan J; School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing, People's Republic of China.
Emerg Microbes Infect ; 11(1): 548-551, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35060840

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 Limite: Animals / Humans Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 Limite: Animals / Humans Idioma: En Revista: Emerg Microbes Infect Ano de publicação: 2022 Tipo de documento: Article